Skip to content
Bandaram Pharma Packtech logo

Bandaram Pharma Packtech

524602 BSE
Price unavailable

Bandaram Pharma Packtech (BANDARAM) share price was ₹19.35 at the 28 Oct 2026 close; market capitalisation ₹34.80 Cr; P/E (TTM) 34.55; sector Healthcare Services. The share price fell 21.9% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue was ₹23.95 Cr, against ₹8.10 Cr a year earlier and net profit was ₹0.68 Cr, against ₹0.02 Cr a year earlier (compared with Jun 2025). Promoters held 62.66% of Bandaram Pharma Packtech in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 39/100 (Weak) as of 28 Oct 2026.

Close 28 Oct 2026 ₹19.35 −4.70 −19.54% 1Y

Key Fundamentals

MicrocapHealthcare ServicesHealthcare
Market Cap
₹34.80 Cr
P/E (TTM)
34.55
EBITDA
₹2.90 Cr
Return on Equity
0.9%
Debt to Equity
0.89
Book Value
₹14.90
EPS (TTM)
₹0.56
52W High
₹49.70
52W Low
₹17.25

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Consolidated · TTM

Peer Comparison

Healthcare › Healthcare Services › Healthcare Service Provider

Dr Lal Pathlabs
₹1,905.4058.9231,982 Cr12.750.26%20.06%25.67%2,996 Cr545 Cr
Vijaya Diagnostic Centre
₹1,433.7078.6514,767 Cr15.430.14%18.07%19.22%879 Cr187 Cr
Metropolis Healthcare
₹548.7556.4011,380 Cr7.580.91%12.54%15.73%1,733 Cr203 Cr
Thyrocare Technologies
₹515.6546.548,207 Cr16.012.84%27.79%33.84%894 Cr176 Cr
Nephrocare Health Services
₹630.30150.436,338 Cr5.680.00%6.88%13.46%1,079 Cr85 Cr
Suraksha Diagnostic
₹319.1046.381,662 Cr6.790.16%12.90%14.70%329 Cr35 Cr
Krsnaa Diagnostics
₹494.6016.221,604 Cr1.640.40%10.35%10.64%862 Cr98 Cr
Bandaram Pharma Packtech (this company)
—34.5535 Cr1.300.52%0.90%4.69%79 Cr1 Cr
Median 8 companies₹548.7551.477,273 Cr7.190.33%12.72%15.22%887 Cr137 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

39 Weak
Overall score

Data confidence 98/100

Category scores

Quality Poor 27
Returns, margins, earnings quality 22% weight
Valuation Weak 37
Cheap vs sector & own history 24% weight
Growth Strong 99
Sales & profit trajectory 9% weight
Financial Health Poor 24
Solvency, leverage, coverage 9% weight
Momentum Poor 17
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company is expected to give good quarter

Weaknesses

4
  • Company has a low return on equity of 5.57% over last 3 years.
  • Company might be capitalizing the interest cost
  • Company has high debtors of 182 days.
  • Promoter holding has decreased over last 3 years: -12.3%

Technical Indicators

Oscillators

Bullish

Bearish
2
Neutral
4
Bullish
3

Overall

Bearish

Bearish
8
Neutral
4
Bullish
7

Moving Averages

Bearish

Bearish
6
Neutral
0
Bullish
4

Growth Rate

Revenue Growth
69.54% higher than 3Y

change over 1 year

Net Income Growth
-70% lower than 3Y

change over 1 year

Cash Flow Change
0.2%

change over 1 year

EBITDA Margin Change
-41.04%

change over 1 year Operating margin 6.47% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
5.87
7.36
7.36
13.43
11.37
7.11
10
8.49
8.1
13.72
14.84
26.26
23.95
Expenses
5.34
6.89
6.89
12.7
10.83
6.02
9.34
7.95
7.47
13.27
13.84
25.44
22.4
Operating Profit
0.53
0.47
0.47
0.73
0.54
1.09
0.66
0.54
0.63
0.45
1
0.82
1.55
OPM %
9.03%
6.39%
6.39%
5.44%
4.75%
15.33%
6.6%
6.36%
7.78%
3.28%
6.74%
3.12%
6.47%
Other Income
0
0
0
0.03
0
0
0
0.09
0
0.01
0
0.01
0
Interest
0.28
0.17
0.17
0.32
0.21
0.26
0.24
-0.1
0.46
0.25
0.33
0.46
0.42
Depreciation
0.18
0.18
0.18
0.19
0.15
0.15
0.15
0.53
0.13
0.14
0.14
0.25
0.2
PBT
0.07
0.12
0.12
0.25
0.18
0.68
0.27
0.2
0.04
0.07
0.53
0.12
0.93
Tax %
0%
0%
0%
24%
0%
0%
103.7%
25%
25%
28.57%
33.96%
25%
25.81%
Net Profit
0.07
0.12
0.12
0.19
0.18
0.67
-0.02
0.15
0.02
0.06
0.35
0.09
0.68
EPS (₹)
0.06
0.1
0.1
0.16
0.15
0.56
-0.01
0.12
0.02
0.02
0.11
0.05
0.38
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
0
18.73
34.08
36.96
62.92
78.77
Expenses
0.01
17.58
31.26
34.13
60.01
74.95
Operating Profit
-0.01
1.15
2.82
2.83
2.91
3.82
OPM %
—
6.14%
8.27%
7.66%
4.62%
4.85%
Other Income
0
0.19
0.03
0.09
0.02
0.02
Interest
0
0.43
0.93
0.99
1.51
1.46
Depreciation
0
0.59
0.73
0.61
0.97
0.73
PBT
-0.01
0.32
1.19
1.32
0.45
1.65
Tax %
0%
21.88%
20.17%
24.24%
35.56%
—
Net Profit
-0.01
0.26
0.95
0.99
0.28
1.18
EPS (₹)
-0.01
0.12
0.79
0.82
0.16
0.56
Div. Payout %
0%
21.43%
12.63%
12.12%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
7.06
3
12
12
17.97
Reserves
-0.06
0.08
0.28
0.65
8.81
Borrowings
0
14.2
12.2
17.15
23.95
Other Liabilities
0.48
2.9
7.58
9.12
25.13
Total Liabilities
7.48
20.18
32.06
38.92
75.86
Fixed Assets
2.87
5.03
4.48
3.95
15.22
CWIP
0
0
0
0
0
Investments
2.09
0
1.4
1.4
0
Other Assets
2.52
15.15
26.18
33.57
60.64
Total Assets
7.48
20.18
32.06
38.92
75.86
Figures in ₹ Crores

Cash Flow

Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
-1.1
-4.13
-4.93
-4.92
Investing
—
-5.3
-1.58
-0.08
0
Financing
—
4.47
5.59
5.09
5.53
Net Cash Flow
—
-1.93
-0.11
0.08
0.6
Free Cash Flow
—
-3.89
-4.31
-5.01
-4.92
CFO/OP
—
-96
-139
-163
-169
Figures in ₹ Crores

Ratios

Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
—
129
156
185
182
Cash Conversion Cycle
—
129
156
185
182
Working Capital Days
—
147
148
165
127
ROCE %
—
5.69%
9.1%
7.67%
4.44%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Bandaram Pharma Packtech insights

58 extracted metrics + investor summaries across FY00–FY27.

Shareholding Pattern

Promot.62.66%Others1.17%Public36.16%As ofSep 2026

Documents

Frequently Asked Questions about Bandaram Pharma Packtech

What does Bandaram Pharma Packtech Ltd do?
Incorporated in 2022, Bandaram Pharma Packtech Ltd deals in procurement and supply of recycled paper[1]
Where is Bandaram Pharma Packtech Ltd (BANDARAM) listed?
Bandaram Pharma Packtech Ltd trades under code 524602 on the BSE.
Which sector does Bandaram Pharma Packtech Ltd belong to?
Bandaram Pharma Packtech Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the market capitalisation of Bandaram Pharma Packtech Ltd?
Bandaram Pharma Packtech Ltd has a market capitalisation of ₹34.8 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Bandaram Pharma Packtech Ltd?
Bandaram Pharma Packtech Ltd trades at a PE ratio of 34.55 as of 28 Oct 2026, on earnings per share of ₹0.56, against a book value of ₹14.9 per share.
What is the 52-week high and low of Bandaram Pharma Packtech Ltd?
Over the last 52 weeks Bandaram Pharma Packtech Ltd has traded between ₹17.25 and ₹49.7 as of 28 Oct 2026.
Does Bandaram Pharma Packtech Ltd pay dividends?
Bandaram Pharma Packtech Ltd has a dividend yield of 0.52%.
What is the Return on Equity (ROE) of Bandaram Pharma Packtech Ltd?
Bandaram Pharma Packtech Ltd reported a return on equity of 0.90%. Its debt-to-equity ratio is 0.89.

Company Information

Incorporated in 2022, Bandaram Pharma Packtech Ltd deals in procurement and supply of recycled paper[1]

Website bandaram.com
CEO Mr. Bandaram Deepak Reddy
Employees 21
Listed 2022-12-22
Face Value ₹ 10
Shares Outstanding 1,79,83,368

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524602.md for Bandaram Pharma Packtech Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month